ClinicalTrials.gg
Drug

Hydralazine clinical trials

Also written Apresoline and MC-1101.

studies test it
31
open now
2
in phase 3
10
first study started
2004

How each study uses Hydralazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Hydralazine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Jan 1953 · APRESOLINE · NDA 008303 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Hydralazine
14

Brand

Apresoline
4

Development codes

MC-1101
3

In one entry with another drug

Given together, or one or the other

Hydralazine and magnesium valproate
4
labetalol/hydralazine/enalapril
2

Studies by the year they started

31 studies that test it; most in 2005 (4)

Studies that test Hydralazine, by start year
YearStudies
20042
20054
20073
20081
20091
20112
20124
20131
20141
20152
20161
20171
20182
20202
20212
20242

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
13
Phase 3
10
Phase 4
3
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 27

National Institute of Cancerología (5) · MacuCLEAR, Inc. (3) · University of Alberta (2) · University of Arkansas (2) · Shahid Sadoughi University of Medical Sciences and Health Services (1) · Muhammad Aamir Latif (1) · Hamilton Health Sciences Corporation (1) · University of Cincinnati (1)

Often tested with

Tested in the same studies.

Labetalol (7) · Isosorbide Dinitrate (4) · Valproic Acid (4) · Enalapril (3) · Nifedipine (2) · Amlodipine (2) · Valsartan (2) · Nicardipine (1)

Studies

Open first, then newest update. How each study uses Hydralazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 31

See all 31 studies that test Hydralazine →

Given beside what is tested · 2 — Hydralazine is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Hydralazine

Codes

What other systems call Hydralazine · ClinicalTrials.gg INT007624

  • MeSH (NLM) D006830HydralazineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 26NAK24LS8HYDRALAZINEConfirmed FDA, NLM, Wikidata
  • RxNorm 5470Confirmed FDA, Wikidata
  • Wikidata Q419987hydralazineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62032HydralazineOne source FDA
  • DrugBank DB01275One source Wikidata

Also registered as hydralazine hydrochloride (UNII FD171B778Y · RxNorm 82027).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.